Literature DB >> 19584398

miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.

Francisco Navarro1, David Gutman, Eti Meire, Mario Cáceres, Isidore Rigoutsos, Zvi Bentwich, Judy Lieberman.   

Abstract

The role of miRNAs in regulating megakaryocyte differentiation was examined using bipotent K562 human leukemia cells. miR-34a is strongly up-regulated during phorbol ester-induced megakaryocyte differentiation, but not during hemin-induced erythrocyte differentiation. Enforced expression of miR-34a in K562 cells inhibits cell proliferation, induces cell-cycle arrest in G(1) phase, and promotes megakaryocyte differentiation as measured by CD41 induction. miR-34a expression is also up-regulated during thrombopoietin-induced differentiation of CD34(+) hematopoietic precursors, and its enforced expression in these cells significantly increases the number of megakaryocyte colonies. miR-34a directly regulates expression of MYB, facilitating megakaryocyte differentiation, and of CDK4 and CDK6, to inhibit the G(1)/S transition. However, these miR-34a target genes are down-regulated rapidly after inducing megakaryocyte differentiation before miR-34a is induced. This suggests that miR-34a is not responsible for the initial down-regulation but may contribute to maintaining their suppression later on. Previous studies have implicated miR-34a as a tumor suppressor gene whose transcription is activated by p53. However, in p53-null K562 cells, phorbol esters induce miR-34a expression independently of p53 by activating an alternative phorbol ester-responsive promoter to produce a longer pri-miR-34a transcript.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584398     DOI: 10.1182/blood-2009-02-205062

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  69 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  MicroRNAs are shaping the hematopoietic landscape.

Authors:  Ute Bissels; Andreas Bosio; Wolfgang Wagner
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

3.  MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit.

Authors:  X Li; J Zhang; L Gao; S McClellan; M A Finan; T W Butler; L B Owen; G A Piazza; Yaguang Xi
Journal:  Cell Death Differ       Date:  2011-10-07       Impact factor: 15.828

Review 4.  Desperately seeking microRNA targets.

Authors:  Marshall Thomas; Judy Lieberman; Ashish Lal
Journal:  Nat Struct Mol Biol       Date:  2010-10       Impact factor: 15.369

5.  MicroRNA expression in maturing murine megakaryocytes.

Authors:  Joanna B Opalinska; Alexey Bersenev; Zhe Zhang; Alec A Schmaier; John Choi; Yu Yao; Janine D'Souza; Wei Tong; Mitchell J Weiss
Journal:  Blood       Date:  2010-08-18       Impact factor: 22.113

Review 6.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

7.  Regulation of miR-34 Family in Neuronal Development.

Authors:  Abhishek Jauhari; Tanisha Singh; Parul Singh; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

8.  Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.

Authors:  Phillip A Angart; Rebecca J Carlson; Kwasi Adu-Berchie; S Patrick Walton
Journal:  Nucleic Acid Ther       Date:  2016-07-11       Impact factor: 5.486

9.  Cyclin-dependent kinase 4 may be expressed as multiple proteins and have functions that are independent of binding to CCND and RB and occur at the S and G 2/M phases of the cell cycle.

Authors:  Yuan Sun; Xiaomin Lou; Min Yang; Chengfu Yuan; Ling Ma; Bing-Kun Xie; Jian-Min Wu; Wei Yang; Steven Xj Shen; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2013-09-24       Impact factor: 4.534

Review 10.  The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.

Authors:  Brian D Adams; Christine Parsons; Frank J Slack
Journal:  Expert Opin Ther Targets       Date:  2015-12-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.